GlassScriptPhysician profile
Alex J Childs
NPI 1790749141
$9,087.95
in general payments reported to CMS, 2019-2025
52 companies · $779 in 2025
The $779 reported for 2025 was more than what 81% of Gynecology providers received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $699 · 2020: $531 · 2021: $4,327 · 2022: $1,317 · 2023: $867 · 2024: $568 · 2025: $779.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,214.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,214.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $4,267.42 | 2019-2025 | Liletta |
| Astellas Pharma US INC | $734.20 | 2019-2025 | Veozah, Myrbetriq |
| Sumitomo Pharma America, INC. | $522.33 | 2023-2025 | Myfembree, Gemtesa |
| Pfizer INC. | $320.30 | 2019-2024 | |
| Axonics, INC. | $250.13 | 2020-2022 | |
| Organon LLC | $221.30 | 2021-2025 | Nexplanon, Jada System |
| Bayer Healthcare Pharmaceuticals INC. | $171.12 | 2022-2025 | |
| Scynexis, INC. | $152.97 | 2021-2022 | |
| Hologic Sales and Service, LLC | $150.62 | 2019-2025 | Myosure Tissue Removal Device, Novasure, Fluent Fluid Management System |
| Myovant Sciences INC. | $141.59 | 2021-2022 | |
| Duchesnay USA Incorporated | $132.50 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $125.88 | 2020-2024 | Xifaxan |
| Amgen INC. | $123.70 | 2019-2021 | |
| Urovant Sciences INC | $123.05 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $121.98 | 2025 | Zeposia |
Show all 52 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myriad Women'S Health, INC. | $115.10 | 2023 | Risk Score |
| Shield Therapeutics INC | $102.88 | 2023-2025 | Accrufer |
| Aspira Women'S Health INC | $99.69 | 2022 | |
| Coopersurgical, INC. | $97.30 | 2020-2024 | Paragard T 380a, Paragard T 380a |
| Exeltis, USA INC. | $86.34 | 2020-2024 | Slynd |
| Pacira Pharmaceuticals Incorporated | $82.17 | 2025 | Exparel |
| Lupin INC. | $79.37 | 2019-2021 | |
| Channel Medsystems, INC. | $73.50 | 2022 | |
| Mayne Pharma Commercial LLC | $60.64 | 2021-2025 | |
| Therapeuticsmd, INC. | $54.54 | 2019-2022 | |
| Minerva Surgical, INC | $53.99 | 2020-2023 | |
| Medtronic, INC. | $52.26 | 2022-2025 | Interstim |
| Mylan Pharmaceuticals INC. | $46.40 | 2019-2022 | |
| Amag Pharmaceuticals, INC. | $43.70 | 2019 | |
| Convatec INC. | $42.80 | 2022-2023 | |
| Evofem Biosciences, INC. | $42.12 | 2021 | |
| Intuitive Surgical, INC. | $38.47 | 2024 | |
| Kerecis Limited | $32.91 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Novo Nordisk INC | $31.21 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $28.23 | 2023 | Seglentis, Livalo |
| Merck Sharp & Dohme LLC | $26.44 | 2020-2021 | |
| Mimedx Group, INC. | $19.96 | 2024 | |
| Coloplast Corp | $18.50 | 2025 | |
| Exact Sciences Corporation | $17.90 | 2025 | Cologuard Collection Kit |
| Virtus Pharmaceuticals LLC | $17.73 | 2021 | |
| Boston Scientific Corporation | $17.09 | 2025 | Axonics |
| Medtronic USA, INC. | $17.05 | 2019 | |
| Lilly USA, LLC | $15.74 | 2024 | Zepbound |
| Conmed Corporation | $13.95 | 2023 | Airseal |
| Allergan, INC. | $13.85 | 2019 | |
| Si-Bone, INC. | $13.79 | 2021 | |
| Sage Therapeutics, LLC | $13.78 | 2023 | |
| Ethicon US, LLC | $13.66 | 2020 | |
| Sanara Medtech INC. | $11.89 | 2021 | |
| Covidien LP | $11.78 | 2019 | |
| Agile Therapeutics, INC. | $11.75 | 2021 | |
| Allegis Pharmaceuticals, LLC | $10.38 | 2023 | Urimar-T Caps |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alex Childs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.